Adaphostin as well as the proteasome inhibitor bortezomib were shown to induce apoptosis in multiple myeloma cells causing c-Abl cleavage and caspase activation in a JUN dependent manner [104]. The gene discussed is ABL1; the disease is plasma cell myeloma.